A Case of Darier’s Disease with a Novel Missense Mutation in ATP2A2 Successfully Treated with Calcipotriol/Betamethasone Dipropionate Two-Compound Ointment

References

• Haber RN, Dib NG. Management of Darier disease: a review of the literature and update. Indian J Dermatol Venereol Leprol. 2021;87:14–21. doi:10.25259/IJDVL_963_19
   PubMed Web of Science ®Google Scholar
• Bashir R, Munro CS, Mason S, Stephenson A, Rees JL, Strachan T. Localisation of a gene for Darier’s disease. Hum Mol Genet. 1993;2:1937–1939. doi:10.1093/hmg/2.11.1937
   PubMed Web of Science ®Google Scholar
• Sakuntabhai A, Ruiz-Perez V, Carter S, et al. Mutations in ATP2A2, encoding a Ca2+ pump, cause Darier disease. Nat Genet. 1999;21:271–277. doi:10.1038/6784
   PubMed Web of Science ®Google Scholar
• Dode L, Andersen JP, Leslie N, Dhitavat J, Vilsen B, Hovnanian A. Dissection of the functional differences between sarco (endo) plasmic reticulum Ca2+-ATPase (SERCA) 1 and 2 isoforms and characterization of Darier disease (SERCA2) mutants by steady-state and transient kinetic analyses. J Biol Chem. 2003;278:47877–47889. doi:10.1074/jbc.M306784200
   PubMed Web of Science ®Google Scholar
• van de Kerkhof PC. The impact of a two-compound product containing calcipotriol and betamethasone dipropionate (Daivobet/ Dovobet) on the quality of life in patients with psoriasis vulgaris: a randomized controlled trial. Br J Dermatol. 2004;151:663–668. doi:10.1111/j.1365-2133.2004.06134.x
   PubMed Web of Science ®Google Scholar
• Onozuka T, Sawamura D, Yokota K, Shimizu H. Mutational analysis of the ATP2A2 gene in two Darier disease families with intrafamilial variability. Br J Dermatol. 2004;150:652–657. doi:10.1111/j.0007-0963.2004.05868.x
   PubMed Web of Science ®Google Scholar
• Cooper SM, Burge SM. Darier’s disease: epidemiology, pathophysiology, and management. Am J Clin Dermatol. 2003;4:97–105. doi:10.2165/00128071-200304020-00003
   PubMed Web of Science ®Google Scholar
• Seo SH, Kim SE, Lee SE. ER stress induced by ER calcium depletion and UVB irradiation regulates tight junction barrier integrity in human keratinocytes. J Dermatol Sci. 2020;98:41–49. doi:10.1016/j.jdermsci.2020.02.006
   PubMed Web of Science ®Google Scholar
• Celli A, Mackenzie DS, Zhai Y, et al. SERCA2-controlled Ca2+-dependent keratinocyte adhesion and differentiation is mediated via the sphingolipid pathway: a therapeutic target for Darier’s disease. J Invest Dermatol. 2012;132:1188–1195. doi:10.1038/jid.2011.447
   PubMed Web of Science ®Google Scholar
• Hobbs RP, Amargo EV, Somasundaram A, et al. The calcium ATPase SERCA2 regulates desmoplakin dynamics and intercellular adhesive strength through modulation of PKCα. FASEB J. 2011;25:990–1001. doi:10.1096/fj.10-163261
   PubMed Web of Science ®Google Scholar
• Pasmatzi E, Badavanis G, Monastirli A, Tsambaos D. Reduced expression of the antiapoptotic proteins of Bcl-2 gene family in the lesional epidermis of patients with Darier’s disease. J Cutan Pathol. 2007;34:234–238. doi:10.1111/j.1600-0560.2006.00600.x
   PubMed Web of Science ®Google Scholar
• Boehmer D, Eyerich K, Darsow U, Biedermann T, Zink A. Variable response to low-dose naltrexone in patients with Darier disease: a case series. J Eur Acad Dermatol Venereol. 2019;33:950–953. doi:10.1111/jdv.15457
   PubMed Web of Science ®Google Scholar
• Lee B, Elston DM. The uses of naltrexone in dermatologic conditions. J Am Acad Dermatol. 2019;80:1746–1752. doi:10.1016/j.jaad.2018.12.031
   PubMed Web of Science ®Google Scholar
• Hanna N, Lam M, Fleming P, Lynde C. Therapeutic options for the treatment of Darier’s disease: a comprehensive review of the literature. J Cutan Med Surg. 2021;12034754211058405. doi:10.1177/12034754211058405
   Web of Science ®Google Scholar
• Burge SM, Wilkinson JD. Darier–White disease: a review of the clinical features in 163 patients. J Am Acad Dermatol. 1992;27:40–50. doi:10.1016/0190-9622(92)70154-8
   PubMed Web of Science ®Google Scholar
• Suwanjang W, Holmström KM, Chetsawang B, Abramov AY. Glucocorticoids reduce intracellular calcium concentration and protects neurons against glutamate toxicity. Cell Calcium. 2013;53:256–263. doi:10.1016/j.ceca.2012.12.006
   PubMed Web of Science ®Google Scholar
• Mayuzumi N, Ikeda S, Kawada H, Ogawa H. Effects of drugs and anticytokine antibodies on expression of ATP2A2 and ATP2C1 in cultured normal human keratinocytes. Br J Dermatol. 2005;152:920–924. doi:10.1111/j.1365-2133.2005.06394.x
   PubMed Web of Science ®Google Scholar
• Kirnbauer R, Köck A, Neuner P, et al. Regulation of epidermal cell interleukin-6 production by UV light and corticosteroids. J Invest Dermatol. 1991;96:484–489. doi:10.1111/1523-1747.ep12470181
   PubMed Web of Science ®Google Scholar
• Bikle DD. 1,25(OH)2D3-modulated calcium induced keratinocyte differentiation. J Investig Dermatol Symp Proc. 1996;1:22–27.
   PubMedGoogle Scholar
• Tang W, Ziboh VA. Agonist/inositol trisphosphate-induced release of calcium from murine keratinocytes: a possible link with keratinocyte differentiation. J Invest Dermatol. 1991;96:134–138. doi:10.1111/1523-1747.ep12515934
   PubMed Web of Science ®Google Scholar
• Gniadecki R, Gajkowska B, Hansen M. 1,25-dihydroxyvitamin D3 stimulates the assembly of adherens junctions in keratinocytes: involvement of protein kinase C. Endocrinology. 1997;138:2241–2248. doi:10.1210/endo.138.6.5156
   PubMed Web of Science ®Google Scholar
• Manggau M, Kim DS, Ruwisch L, et al. 1alpha,25-dihydroxyvitamin D3 protects human keratinocytes from apoptosis by the formation of sphingosine-1-phosphate. J Invest Dermatol. 2001;117:1241–1249. doi:10.1046/j.0022-202x.2001.01496.x
   PubMed Web of Science ®Google Scholar
• Kragballe K, Steijlen PM, Ibsen HH, et al. Efficacy, tolerability, and safety of calcipotriol ointment in disorders of keratinization. Results of a randomized, double-blind, vehicle-controlled, right/left comparative study. Arch Dermatol. 1995;131:556–560. doi:10.1001/archderm.1995.01690170058008
   PubMed Web of Science ®Google Scholar
• Mills CM, Marks R. Side effects of topical glucocorticoids. Curr Probl Dermatol. 1993;21:122–131.
   PubMedGoogle Scholar